Date Filed | Type | Description |
02/16/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/26/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019133 |
07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019131 |
07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019129 |
07/01/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019128 |
06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
06/30/2009 |
S-8 POS
| Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
06/30/2009 |
POS AM
| Form POS AM -- Post-Effective amendments for registration statement |
06/30/2009 |
S-8 POS
| Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/30/2009 |
S-8 POS
| Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments |
06/30/2009 |
15-12B
| Form 15-12B -- Securities registration termination [Section 12(b)] |
06/02/2009 |
8-K
| Quarterly results |
05/28/2009 |
25-NSE
| Form 25-NSE -- |
05/13/2009 |
10-Q
| Quarterly Report for the period ended March 31, 2009 |
05/06/2009 |
8-K
| Form 8-K -- Current report |
05/06/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
04/28/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
04/02/2009 |
8-K
| Form 8-K -- Current report |
04/02/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
03/31/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
03/17/2009 |
8-K
| Form 8-K -- Current report |
03/10/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/17/2009 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 4.6% stake in AVALON PHARMACEUTICALS, INC. |
02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/11/2009 |
SC 13D/A
| OBP Management III L.P. has filed a Schedule 13D for Avalon Pharmaceuticals, Inc. |
01/30/2009 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 6.1% stake in Avalon Pharmaceuticals Inc. |
01/21/2009 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8.2% stake in Avalon Pharmaceuticals, Inc. |
01/14/2009 |
8-K
| Form 8-K -- Current report |
01/14/2009 |
425
| Form 425 -- Prospectuses and communications, business combinations |
12/22/2008 |
8-K
| Form 8-K -- Current report |
11/25/2008 |
8-K
| Form 8-K -- Current report |
|